期刊文献+

原发性肝癌患者中血小板与血浆VEGF水平差异及意义的研究 被引量:2

The research of difference and significance between platelet and serum VEGF level in HCC patients
在线阅读 下载PDF
导出
摘要 目的:探讨原发性肝癌(HCC)患者血小板和血浆VEGF含量差异及其意义。方法:采用ELISA与BCA法检测30例HCC患者及10例健康者血小板和血浆VEGF的含量与总蛋白量,进行对比研究。结果:(1)HCC患者血小板VEGF相对值(VEGF含量/样本总蛋白含量)为(235.75±117.47)pg/mg,血浆VEGF相对值为(1.19±0.59)pg/mg,差异具有统计学意义(P<0.05);(2)健康组血小板与血浆VEGF相对值对比,血小板VEGF相对值(73.42±32.54)pg/mg高于血浆VEGF相对值(0.32±0.12)pg/mg,差异有统计学意义(P<0.05);(3)HCC患者血小板VEGF相对值为(235.75±117.47)pg/mg,与健康组(73.42±32.54)pg/mg相比,其相对值高于健康组,差异具有统计学意义(P<0.05);(4)HCC患者血浆VEGF相对值与健康组血浆VEGF相对值对比,HCC患者血浆VEGF相对值(1.19±0.59)pg/mg高于健康组(0.32±0.12)pg/mg,差异无统计学意义(P>0.05)。结论:(1)HCC患者和健康人血小板VEGF相对值都远高于血浆,提示血小板中VEGF相对更浓聚。(2)与健康人相比,HCC患者血小板中VEGF含量明显升高,而两者血浆VEGF含量无统计学差异,提示以血小板为样本,而不是血浆,更有利于发现HCC患者VEGF水平的变化,即可能更早发现肿瘤的生长。 Objective :To evaluate the difference between platelet and serum VEGF level in HCC patients. Methods:Plate- let and serum VEGF,and albumin from 30 HCC and 10 healthy patients were evaluated by ELISA and BCA,and the rela- tionship were evaluated by statistic analysis. Results: ( 1 ) In HCC patients, platelet VEGF relative value ( platelet VEGF/ albumin) was (235.75 ±117.47) pg/mg,and serum VEGF relative value (platelet VEGF/albumin) was (1.19± 0.59) pg/mg, there was significant difference (P 〈 0.05 ). (2)In healthy patients, platelet VEGF value (73.42 ± 32.54) pg/mg was significantly higher than serum VEGF (0.32 ±0. 12) pg/mg ( P 〈 0.05 ). ( 3 ) Platelet VEGF relative value was much higher in HCC patients (235.75 ±117.47 ) pg/mg than healthy patients (73.42± 32.54) pg/mg( P 〈 0.05 ). (4) There was no significant difference of serum VEGF between HCC and healthy patients. Conclusion: ( 1 ) Plate- let VEGF level is much higher than serum both in HCC and healthy patients. (2) Platelet VEGF is increased in HCC pa- tients compared with healthy people, but serum VEGF is with no difference,indicating that platelet VEGF is much more useful for evaluating the invasion of HCC.
出处 《赣南医学院学报》 2012年第4期508-510,共3页 JOURNAL OF GANNAN MEDICAL UNIVERSITY
基金 江西省卫生厅重大科技项目(20090413) 江西省教育厅重点项目(GJJ10028)
关键词 血小板 蛋白质 VEGF HCC platelet albumin VEGF HCC
作者简介 通讯作者:刘潜,男,博士,外科学教授,硕士生导师,E-mail:liuqianGMU@126.com
  • 相关文献

参考文献10

  • 1陈建国.中国肝癌发病趋势和一级预防[J].临床肝胆病杂志,2012,28(4):256-260. 被引量:112
  • 2Senger DR,Galli ST,Dvork AM,et al.Tumor cells secretea vascular permeability factor that promotes accumulationof ascites fluid[J].science,1983,219(4587):983-985.
  • 3Iovino F,Ferraravvlo F,Orditura M,et,al.Serum Vascularendothelial growth factor levels correlate with tumor VEGFand P53 overexpression in endocrine positive primarybreast cancer[J].Cancer luvest,2008,26:250-253.
  • 4杨贵义.原发性肝癌患者血清和血浆中VEGF检测的临床意义[J].医学新知,2009(6):331-333. 被引量:3
  • 5林丹霞,林英城,况丽平,吴贤英,吴铭耀,李德锐.食管鳞癌组织VEGF和Angiopoietin-2表达及其临床意义的研究[J].中华肿瘤防治杂志,2008,15(4):268-270. 被引量:11
  • 6Wang XL,Ai ZS,Fang JP,et al.Expression of Vascularendothelial growth factors(VEGF)-A-Cand-Dand theirprognostic significance and relationship with angio-andlymphangiogenesis in gastric cancer[J].zhonghua zhong-liu za zhi,2008,30:837-843.
  • 7Svendsen MN,Lykke J,Werther K,et al.Concentrationsof VEGF and VEGFR1 in paired tumor arteries and veinsin patients with rectal cancer[J].Oncol Res,2004,14(11-12):611-615.
  • 8George ML,Eccles SA,Tutton MG,et al.Correlation ofplasma and serum vascular endothelial growth factor lev-els with platelet count in colorectal cancer:clinical evi-dence of platelet scavenging?[J].Clin Cancer Res,2000,6(8):3147-3152.
  • 9Jon E.Peterson,Zurakowski D,Italiano JE Jr,et al.Nor-mal ranges of angiogenesis regulatory proteins in humanplatelets[J].Am J Hematol,2010,85(7):487-493.
  • 10顾阳春,马力文.循环VEGF的临床意义[J].癌症进展,2010,8(3):267-270. 被引量:4

二级参考文献75

  • 1陈建国,朱健,张永辉,朱源荣,陆建华.江苏省启东地区1973至2002年肝癌发病率长期趋势的评价[J].中华医学杂志,2005,85(43):3052-3056. 被引量:53
  • 2Carmeliet P,Jainn R K. Angiogenesis in cancer and other diseases [ J ]. Nature,2000,407:249-257.
  • 3Coskun U, Gunel N, Toruner F B,et al. Serum leptin, prolactin and vascular endothelial growth factor (VEGF) levels in patients with breast cancer [ J]. Neoplasma, 2003,50 ( 1 ) :41-46.
  • 4Chin K F, Greenman J, Reusch P, et al. Vascular endothelial growth factor and soluble Tie-2 receptor in colorectal cancer: associations with disease recurrence [ J]. European journal of surgical oncology ,2003,29 ( 6 ) :497-505.
  • 5Banks R E, Forbes M A, Kinsey S E,et al. Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: significance for VEGF measurements and cancer biology [ J ]. Br J Cancer, 1998,77:956- 964.
  • 6McDonnell C O, Harmey J H, Bouchier-Hayes D J, et al. Effect of muhimodality therapy on circulating vascular endothelial growth factor levels in patients with oesophageal cancer[ J]. Br J Surg,2001,88 : 1105-1109.
  • 7Kut C,Mac Gabhann F,Popel AS.Where is vegf in the body? A meta-analysis of vegf distribution in cancer[J].Br J Cancer,2007,97:978.
  • 8Hawinkels LJAC,Zuidwijk K,Verspaget HW,et al.Vegf release by mmp - 9 mediated heparan sulphate cleavage induces colorectal cancer angiogenesis[J].Eur J Cancer,2008,44:1904.
  • 9Salgado R,Benoy I,Weytjens R,et al.Arterio-venous gradients of il-6,plasma and serum vegf and d-dimers in human cancer[J].Br J Cancer,2002,87:1437.
  • 10Svendsen MN,Lykke J,Werther K,et al.Concentrationsof vegf and vegfrl in paired tumor arteries and veins in pa-tients with rectal cancer[J].Oncol Res,2004,14:611.

共引文献126

同被引文献14

引证文献2

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部